Your browser doesn't support javascript.
loading
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study.
Rashidi-Ranjbar, Neda; Churchill, Nathan W; Black, Sandra E; Kumar, Sanjeev; Tartaglia, Maria C; Freedman, Morris; Lang, Anthony; Steeves, Thomas D L; Swartz, Richard H; Saposnik, Gustavo; Sahlas, Dametrios; McLaughlin, Paula; Symons, Sean; Strother, Stephen; Pollock, Bruce G; Rajji, Tarek K; Ozzoude, Miracle; Tan, Brian; Arnott, Stephen R; Bartha, Robert; Borrie, Michael; Masellis, Mario; Pasternak, Stephen H; Frank, Andrew; Seitz, Dallas; Ismail, Zahinoor; Tang-Wai, David F; Casaubon, Leanne K; Mandzia, Jennifer; Jog, Mandar; Scott, Christopher J M; Dowlatshahi, Dar; Hassan, Ayman; Grimes, David; Marras, Connie; Zamyadi, Mojdeh; Munoz, David G; Ramirez, Joel; Berezuk, Courtney; Holmes, Melissa; Fischer, Corinne E; Schweizer, Tom A.
Afiliación
  • Rashidi-Ranjbar N; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Churchill NW; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Black SE; Division of Neurology, Department of Medicine, Sunnybrook HSC, University of Toronto, Toronto, Ontario, Canada.
  • Kumar S; L.C. Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Research Program Sunnybrook Health Sciences Research Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Tartaglia MC; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Freedman M; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Lang A; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
  • Steeves TDL; Division of Neurology, Department of Medicine, Sunnybrook HSC, University of Toronto, Toronto, Ontario, Canada.
  • Swartz RH; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
  • Saposnik G; Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Sahlas D; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • McLaughlin P; The Edmond J. Safra Program in Parkinson's Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Symons S; Division of Neurology, Department of Medicine, Sunnybrook HSC, University of Toronto, Toronto, Ontario, Canada.
  • Strother S; Division of Neurology, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Pollock BG; Division of Neurology, Department of Medicine, Sunnybrook HSC, University of Toronto, Toronto, Ontario, Canada.
  • Rajji TK; L.C. Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Research Program Sunnybrook Health Sciences Research Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Ozzoude M; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Tan B; Clinical Outcomes and Decision Neuroscience Unit, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Arnott SR; McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.
  • Bartha R; Nova Scotia Health, Halifax, Nova Scotia, Canada.
  • Borrie M; Departments of Medicine (Geriatrics) and Psychology & Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Masellis M; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Pasternak SH; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
  • Frank A; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Seitz D; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Ismail Z; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Tang-Wai DF; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Casaubon LK; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Mandzia J; L.C. Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Research Program Sunnybrook Health Sciences Research Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Jog M; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Scott CJM; Department of Psychology, Faculty of Health, York University, Toronto, Ontario, Canada.
  • Dowlatshahi D; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
  • Hassan A; Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
  • Grimes D; Robarts Research Institute, Western University, London, Ontario, Canada.
  • Marras C; Nova Scotia Health, Halifax, Nova Scotia, Canada.
  • Zamyadi M; Departments of Medicine (Geriatrics) and Psychology & Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Munoz DG; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Ramirez J; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Berezuk C; St. Joseph's Healthcare Centre, London, Ontario, Canada.
  • Holmes M; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Fischer CE; St. Joseph's Healthcare Centre, London, Ontario, Canada.
  • Schweizer TA; Bruyère Research Institute, Ottawa, Ontario, Canada.
Int J Geriatr Psychiatry ; 39(3): e6074, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38491809
ABSTRACT

OBJECTIVES:

Neuropsychiatric symptoms (NPS) increase risk of developing dementia and are linked to various neurodegenerative conditions, including mild cognitive impairment (MCI due to Alzheimer's disease [AD]), cerebrovascular disease (CVD), and Parkinson's disease (PD). We explored the structural neural correlates of NPS cross-sectionally and longitudinally across various neurodegenerative diagnoses.

METHODS:

The study included individuals with MCI due to AD, (n = 74), CVD (n = 143), and PD (n = 137) at baseline, and at 2-years follow-up (MCI due to AD, n = 37, CVD n = 103, and PD n = 84). We assessed the severity of NPS using the Neuropsychiatric Inventory Questionnaire. For brain structure we included cortical thickness and subcortical volume of predefined regions of interest associated with corticolimbic and frontal-executive circuits.

RESULTS:

Cross-sectional analysis revealed significant negative correlations between appetite with both circuits in the MCI and CVD groups, while apathy was associated with these circuits in both the MCI and PD groups. Longitudinally, changes in apathy scores in the MCI group were negatively linked to the changes of the frontal-executive circuit. In the CVD group, changes in agitation and nighttime behavior were negatively associated with the corticolimbic and frontal-executive circuits, respectively. In the PD group, changes in disinhibition and apathy were positively associated with the corticolimbic and frontal-executive circuits, respectively.

CONCLUSIONS:

The observed correlations suggest that underlying pathological changes in the brain may contribute to alterations in neural activity associated with MBI. Notably, the difference between cross-sectional and longitudinal results indicates the necessity of conducting longitudinal studies for reproducible findings and drawing robust inferences.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Trastornos Cerebrovasculares / Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Humans Idioma: En Revista: Int J Geriatr Psychiatry Asunto de la revista: GERIATRIA / PSIQUIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Trastornos Cerebrovasculares / Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Humans Idioma: En Revista: Int J Geriatr Psychiatry Asunto de la revista: GERIATRIA / PSIQUIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Canadá